866-997-4948(US-Canada Toll Free)

Global Human Microbiome Therapeutics Market 2018-2022

Published By :

Technavio

Published Date : Dec 2017

Category :

Cardiovascular Devices

No. of Pages : 106 Pages

About Human Microbiome Therapeutics
Microbiome Therapeutics is developing evidence-based microbiome modulators designed to shift bacterial populations and their environment in the gastrointestinal (GI) tract to better manage serious health conditions. GIT is an organ system that includes the mouth, esophagus, stomach, and the intestines. The GIT can be divided into upper Git and lower GIT. Upper GIT consists of the oral cavity, the pharynx, the esophagus, the stomach, and the duodenum. The lower GIT consists of the small and large intestines. Gastrointestinal disorders refer to diseases involving the GIT. Microbiome therapeutics are being increasingly adopted for the treatment of gastrointestinal disorders such as IBS and ulcerative colitis.

Technavios analysts forecast the global human microbiome therapeutics market to grow at a CAGR of 14.19% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global human microbiome therapeutics market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of human microbiome therapeutics.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Human Microbiome Therapeutics market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
ENTEROME Bioscience
Rebiotix
Seres Therapeutics
Vedanta Biosciences
Other prominent vendors
Bristol-Myers Squibb
Johnson & Johnson
Takeda Pharmaceutical

Market driver
Side effects of the existing treatments
For a full, detailed list, view our report


Market trend
Growing investments from venture capitalists
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2022 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?


You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.



Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
Market outline
PART 05: MARKET LANDSCAPE
Market ecosystem
Market segmentation analysis
PART 06: MARKET SIZING
Market definition
Market size and forecast
PART 07: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 08: PIPELINE LANDSCAPE
PART 09: MARKET SEGMENTATION BY THERAPEUTIC APPLICATION
Comparison by therapeutic application
Gastrointestinal disorders
Immunological conditions
Others
Market opportunity by therapeutic application
PART 10: CUSTOMER LANDSCAPE
PART 11: REGIONAL LANDSCAPE
Comparison by region
Human microbiome therapeutics market in Americas
Human microbiome therapeutics market in EMEA
Human microbiome therapeutics market in APAC
Key leading countries
Market opportunity by region
PART 12: DECISION FRAMEWORK
PART 13: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 14: MARKET TRENDS
Increase in industry-academia collaboration
Increasing investments by venture capitalists
PART 15: VENDOR LANDSCAPE
Overview
Landscape disruption
Competitive analysis
PART 16: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
ENTEROME Bioscience
Rebiotix
Seres Therapeutics
Vedanta Biosciences
PART 17: APPENDIX
List of abbreviations
List of Exhibits
Exhibit 01: Microbiome by host
Exhibit 02: Common prebiotics
Exhibit 03: Major sources of prebiotics
Exhibit 04: Benefits of probiotics
Exhibit 05: Parent market
Exhibit 06: Global human microbiome therapeutics market: Characteristics
Exhibit 07: Global human microbiome therapeutics market: Segmentation
Exhibit 08: Market definition: Inclusions and exclusions checklist
Exhibit 09: Market size 2017
Exhibit 10: Validation techniques employed for market sizing 2017
Exhibit 11: Global human microbiome therapeutics market 2017-2022 ($ millions)
Exhibit 12: Global human microbiome therapeutics market: Year-over-year growth
Exhibit 13: Five forces analysis 2017
Exhibit 14: Five forces analysis 2022
Exhibit 15: Bargaining power of buyers
Exhibit 16: Bargaining power of suppliers
Exhibit 17: Threat of new entrants
Exhibit 18: Threat of substitutes
Exhibit 19: Threat of rivalry
Exhibit 20: Market condition: Five forces 2017
Exhibit 21: Pipeline landscape
Exhibit 22: Key clinical trials
Exhibit 23: Global human microbiome therapeutics market by therapeutic application 2017-2022 (% share)
Exhibit 24: Comparison by therapeutic application
Exhibit 25: Global human microbiome therapeutics market by gastrointestinal disorders 2017-2022 ($ millions)
Exhibit 26: Global human microbiome therapeutics market by gastrointestinal disorders: Year-over-year growth 2018-2022
Exhibit 27: Global human microbiome therapeutics market by immunological conditions 2017-2022 ($ millions)
Exhibit 28: Global human microbiome therapeutics market by immunological conditions: Year-over-year growth 2018-2022
Exhibit 29: Global human microbiome therapeutics market by others 2017-2022 ($ millions)
Exhibit 30: Global human microbiome therapeutics market by others: Year-over-year growth 2018-2022
Exhibit 31: Market opportunity by therapeutic application
Exhibit 32: Customer landscape
Exhibit 33: Global human microbiome therapeutics market by region 2017-2022 (% share)
Exhibit 34: Regional comparison
Exhibit 35: Human microbiome therapeutics market in Americas 2017-2022 ($ millions)
Exhibit 36: Human microbiome therapeutics market in Americas: Year-over-year growth
Exhibit 37: Human microbiome therapeutics market in EMEA 2017-2022 ($ millions)
Exhibit 38: Human microbiome therapeutics market in EMEA: Year-over-year growth 2018-2022
Exhibit 39: Human microbiome therapeutics market in APAC 2017-2022 ($ millions)
Exhibit 40: Human microbiome therapeutics market in APAC: Year-over-year growth 2018-2022
Exhibit 41: Top Asian countries in terms of population with diabetes (millions)
Exhibit 42: Key leading countries
Exhibit 43: Market opportunity by region
Exhibit 44: Global obesity facts 2014
Exhibit 45: Factors causing changes in human microbiome
Exhibit 46: Antibiotic resistance steps
Exhibit 47: Vendor landscape
Exhibit 48: Landscape disruption
Exhibit 49: Competitive structure analysis of global microbiome therapeutics market
Exhibit 50: Vendors covered
Exhibit 51: Vendor classification
Exhibit 52: Market positioning of vendors
Exhibit 53: ENTEROME Bioscience: Overview
Exhibit 54: ENTEROME Bioscience: Business segments
Exhibit 55: ENTEROME Bioscience: Organizational developments
Exhibit 56: ENTEROME Bioscience: Geographic focus
Exhibit 57: ENTEROME Bioscience: Segment focus
Exhibit 58: ENTEROME Bioscience: Key offerings
Exhibit 59: Rebiotix: Overview
Exhibit 60: Rebiotix: Business segments
Exhibit 61: Rebiotix: Organizational developments
Exhibit 62: Rebiotix: Geographic focus
Exhibit 63: Rebiotix: Segment focus
Exhibit 64: Rebiotix: Key offerings
Exhibit 65: Seres Therapeutics: Overview
Exhibit 66: Seres Therapeutics: Business segments
Exhibit 67: Seres Therapeutics: Organizational developments
Exhibit 68: Seres Therapeutics: Geographic focus
Exhibit 69: Seres Therapeutics: Segment focus
Exhibit 70: Seres Therapeutics: Key offerings
Exhibit 71: Vedanta Biosciences: Overview
Exhibit 72: Vedanta Biosciences: Business segments
Exhibit 73: Vedanta Biosciences: Organizational developments
Exhibit 74: Vedanta Biosciences: Geographic focus
Exhibit 75: Vedanta Biosciences: Segment focus
Exhibit 76: Vedanta Biosciences: Key offerings

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *